Ryvu

company

About

Ryvu is a biopharmaceutical company developing small molecule therapies that address clinical limitations of current treatments in oncology.

  • 101 - 250

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
€20M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2007
Number Of Employee
101 - 250
Operating Status
Active

Ryvu is a biopharmaceutical company developing small-molecule therapies that address the clinical limitations of current treatments in oncology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€42M
Ryvu has raised a total of €42M in funding over 2 rounds. Their latest funding was raised on Nov 30, 2022 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 30, 2022 Post-IPO Equity €20M 1 BioNTech Detail
Aug 17, 2022 Post-IPO Debt €22M 1 European Investment Bank Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Ryvu is funded by 2 investors. BioNTech and European Investment Bank are the most recent investors.
Investor Name Lead Investor Funding Round
BioNTech Yes Post-IPO Equity
European Investment Bank Yes Post-IPO Debt